Related Experiment Video
Updated: May 9, 2026

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism
Published on: October 17, 2025
Atypical developmental patterns of brain chemistry in children with autism spectrum disorder
Insights
Brain chemical changes in children with autism spectrum disorder (ASD) differ from those with developmental delay (DD). Early reductions in brain chemicals in ASD normalize, unlike the persistent changes seen in DD.
Area of Science:
- Neuroscience
- Developmental Pediatrics
- Biochemistry
Background:
- Autism spectrum disorder (ASD) is a neurodevelopmental condition with unclear pathophysiology.
- Early childhood onset of ASD symptoms necessitates understanding early brain changes.
Purpose of the Study:
- To investigate longitudinal brain chemical concentration patterns in children with ASD and developmental delay (DD) across three age groups.
- To compare these patterns with typically developing (TD) children.
Main Methods:
- Proton magnetic resonance spectroscopic imaging was used to measure brain chemical concentrations (NAA, Cho, Cr, mI, Glx) in gray matter (GM) and white matter (WM).
- Data were collected longitudinally for ASD and DD groups and cross-sectionally for TD groups at ages 3-4, 6-7, and 9-10 years.
- Rates of chemical change between ages 3 and 10 were calculated.
Main Results:
- At 3-4 years, children with ASD showed lower NAA, Cho, and Cr in GM and WM compared to TD children; these differences diminished by 9-10 years.
- Children with DD exhibited reduced GM and WM NAA at 3-4 years, with persistent GM NAA reduction at 9-10 years.
- Distinct differences in the rates of change for GM NAA, Cho, and Cr were observed between ASD and DD groups.
Conclusions:
- Gray matter chemical alterations between ages 3 and 10 years differentiate children with ASD from those with DD.
- A dynamic reversal of reduced GM NAA was observed in children with ASD.
- Persistent GM NAA reductions in DD suggest a different, more static developmental process.
Importance:
Autism spectrum disorder (ASD) is a neurodevelopmental disorder with symptoms emerging during early childhood. The pathophysiology underlying the disorder remains incompletely understood.
Objective:
To examine cross-sectional and longitudinal patterns of brain chemical concentrations in children with ASD or idiopathic developmental delay (DD) from 3 different age points, beginning early in the clinical course.
Design:
Proton magnetic resonance spectroscopic imaging data were acquired longitudinally for children with ASD or DD, and primarily cross-sectionally for children with typical development (TD), at 3 to 4, 6 to 7, and 9 to 10 years of age.
Setting:
Recruitment, diagnostic assessments, and magnetic resonance imaging were performed at the University of Washington in Seattle.
Participants:
Seventy-three children (45 with ASD, 14 with DD, and 14 with TD) at 3 to 4 years of age; 69 children (35 with ASD, 14 with DD, and 20 with TD) at 6 to 7 years of age; and 77 children (29 with ASD, 15 with DD, and 33 with TD) at 9 to 10 years of age.
Main Outcomes And Measures:
Concentrations of N-acetylaspartate (NAA), choline (Cho), creatine (Cr), myo-inositol (mI), and glutamine plus glutamate (Glx) in cerebral gray matter (GM) and white matter (WM) at 3 to 4, 6 to 7, and 9 to 10 years of age, and calculation of rates of change of these chemicals between 3 and 10 years of age.
Results:
At 3 to 4 years of age, the ASD group exhibited lower NAA, Cho, and Cr concentrations than did the TD group in both GM and WM, alterations that largely were not observed at 9 to 10 years of age. The DD group exhibited reduced GM and WM NAA concentrations at 3 to 4 years of age; GM NAA concentrations remained reduced at 9 to 10 years of age compared with the TD group. There were distinct differences between the ASD and DD groups in the rates of GM NAA, Cho, and Cr changes between 3 and 10 years of age.
Conclusions And Relevance:
The GM chemical changes between 3 and 10 years of age differentiated the children with ASD from those with DD. Most notably, a dynamic reversal of GM NAA reductions was observed in the children with ASD. By contrast, persistent GM NAA reductions in the children with DD suggest a different, more static, underlying developmental process.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Gut-Brain Axis
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Oppositional Defiant Disorder
Diagnostic Criteria and...
